Email Updates

You are here

Home

2 OCTOBER 2020 VOLUME 22 ISSUE 38

Media Coverage

  • N$1.5 billion war chest to fight HIV

    The US President’s Emergency Plan for AIDS Relief (PEPFAR) will contribute about N$1.5 billion (US$89 million) to Namibia in 2021 for HIV/AIDS programmes. The funding is an increase of about N$200 million from the N$1.3 billion (US$81 million) that the programme provided this year.

    October 1, 2020
    General
    New Era Live

  • Weight Gain Worries for Newer HIV Treatment Regimens

    A South African study has found that a substantial number of women with HIV become obese on newer antiretroviral drug regimens. The study, published in The Lancet HIV on Thursday, shows the importance of local HIV drug trials.

    October 1, 2020
    Treatment
    Daily Maverick

  • Timothy Ray Brown, First Patient Cured of HIV, Dies at 54

    Timothy Ray Brown, the first person to be cured of HIV, through an experimental bone marrow transplant that offered hope though not a realistic treatment for most people with the virus, died on Tuesday at his home in Palm Springs, Calif. He was 54.

    September 30, 2020
    General
    New York Times

  • Truvada Patent Expires, Potentially Opening ‘New Doors’ for PrEP Access

    The patent for the HIV medication Truvada expired today, potentially creating an opportunity for a generic PrEP option for patients. “The real question will be whether this transition affects access, both through insurance plans that might select a less expensive option or through lower direct costs to patients themselves. One key question is whether the cost will be materially different, however,” Jeanne M. Marrazzo, MD, MPH, Infectious Diseases News Editorial Board Member and director of the division of infectious diseases at University of Alabama at Birmingham School of Medicine, told Healio.

    September 30, 2020
    PrEP
    Healio

  • Medical Mistrust Impedes Black Women’s HIV-Related Care

    A recent focus group–based study of Black women living in the South found they often harbored mistrust of a medical system they viewed as structurally and systemically racist. Such feelings, researchers argue, are key barriers to women in this demographic receiving quality HIV prevention services as well as care and treatment if they are living with the virus.

    September 30, 2020
    General
    POZ

  • What If We Could Finally Cure Herpes? This Scientist Is on the Case

    In May 2020, the World Health Organization (WHO) estimated that around half a billion people worldwide are living with genital herpes, and several billion have oral herpes. While there are antiviral medications available to help reduce symptoms, there is no cure.

    September 29, 2020
    General
    The Body

  • Uncapped PrEP Access to Be Rolled Out Across England

    Councils around England will now be able to offer uncapped access to PrEP, the revolutionary HIV prevention medication for those who need it. It was announced earlier this year that the DHSC had set aside a budget for local authorities in England to deliver PrEP to those “who need it most”.

    September 28, 2020
    PrEP
    The Gay UK

  • Could the National HIV Strategy Help Guide the COVID Fight?

    We're now 6 months or 9 months into the COVID-19 pandemic, depending on whether you count from the recognition of the first cases in China in January or the decision to begin locking down the United States in March. More than 200,000 Americans have died—nearly 25 percent of the deaths worldwide—and almost 7 million others have either tested positive or fallen ill and recovered.

    September 28, 2020
    General
    WIRED

Published Research

Announcements